Strides Pharma Science Ltd has informed BSE that a meeting of Board of Directors of the Company is scheduled to be held on July 29, 2019, inter alia, to consider and approve: inter alia: 1. Unaudited financial results (standalone and consolidated) of the Company for the quarter ended June 30, 2019 (Q1). 2. Declaration of Interim Dividend, if any, to the equity shareholders of the Company for the Financial Year 2019-20. Further, as per the provisions of the Company’s Code for Prevention of Insider Trading, trading window for designated employees of the Company is closed from July 01, 2019 to July 31, 2019 (both days inclusive).

Pdf Link: Strides Pharma Science Ltd - Board to consider Q1 results & Interim Dividend on July 29, 2019

Source : BSE - www.bseindia.com

comment COMMENT NOW